Here are the 10-Q quarterly reports from Keen Vision Acquisition Corporation (KVAC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow KVAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KVAC filings page.
Keen Vision Acquisition Corporation is a blank check company seeking a business combination and has not begun operating activities beyond IPO and deal search. As of June 30, 2026, total assets were $13.5 million, down sharply from $57.0 million, mainly due to redemptions that reduced cash and investments in the trust account to $13.4 million.
The company reported net income of $71,966 for the six months ended June 30, 2026, driven by $442,106 of dividend income on trust investments, partially offset by formation and operating costs. Working capital was negative, with a reported deficit of $4.63 million, including $2.91 million of extension promissory notes payable to the sponsor and $1.77 million advanced from a related party.
Management disclosed substantial doubt about the company’s ability to continue as a going concern if it does not complete a business combination by October 27, 2026. Numerous extensions have been funded by sponsor loans, and most public shares have been redeemed, leaving 1,090,446 ordinary shares subject to possible redemption and 4,592,855 shares outstanding overall. After quarter-end, the company’s securities were delisted from Nasdaq and began trading over the counter.
Keen Vision Acquisition Corporation filed its quarterly report for the three months ended March 31, 2026, showing it remains a pre‑revenue SPAC focused on completing a business combination. The company reported net income of $92,087, driven mainly by $324,931 of dividend income on funds held in its trust account, offset by $232,844 of formation and operating costs.
Following large shareholder redemptions, cash and investments in the trust account fell to $13,153,709 from $57,003,115 at December 31, 2025. The company recorded a working capital deficit of $4,373,486 and total liabilities of $7,467,809, including $2,788,022 of extension promissory notes and $1,582,880 due to a related party. As of May 6, 2026, 5,506,521 ordinary shares were issued and outstanding, of which 1,090,446 were subject to possible redemption as of March 31, 2026.
The report describes multiple trust agreement amendments and extension loans from the sponsor to push the deadline to complete a business combination to July 27, 2026. Management discloses that these factors, together with the company’s limited cash outside the trust account, raise substantial doubt about its ability to continue as a going concern if it does not close a business combination by that date.